Skip to main content
. 2013 Jul 9;8(7):e69144. doi: 10.1371/journal.pone.0069144

Table 1. Characteritics of the 8 recipients.

Recipient 1 2 3 4 5 6 7 8
Date of sample collection 2/12/2002 3/25/1998 01/02/1999 6/26/2000 3/1/1999 4/18/2007 6/16/1999 10/24/2008
Estimated time since infection (days) 33 37 37 40 43 85 32 38
HIV-1 RNA (log10 copies/mL) 5.93 4.70 4.44 5.52 6.07 4.01 4.83 4.62
HIV-1 DNA (log10 copies/10e6 PBMC) 3.25 3.12 3.15 2.86 3.64 2.76 3.84 ND
CD4 cell count (cells/mm3) 520 734 368 681 381 635 558 523
Viral subtype B B B B B B B B
Viral resistance 0 0 0 0 0 0 0 0
Age (years) 38 28 36 21 28 39 29 19
Gender (male/female) M M F M F M M F
Risk group Het MSM Het MSM Het MSM MSM Het
Country of birth France Chile France France Algeria France France France
Living place France France France(West Indies) France (West Indies) France France France France (West Indies)
Number of regular sexual partners * 1 1 1 1 1 0 0 1
Number of casual sexual partners * 0 15 0 0 0 5 3 0
Serological syphilis testing
HBV testing
HBsAg
HBsAb + +
HBcAb +
HBV DNA (log10 IU/mL) n.d. Und. n.d. n.d. n.d. n.d. n.d. n.d.
HCV testing
HCV Ab +
HCV RNA (log10 IU/mL) n.d. 1.7 n.d. n.d. n.d. n.d. n.d. n.d.
Prior sexually transmitted infections § Condyloma No Vaginal candidiasis No No No Condyloma No
*

In the 6 months preceding PHI diagnosis.

§

Urethritis, rectitis, genital herpes infection, vulvo-vaginal candidosis, condyloma and/or syphilis.

PBMC = peripheral blood mononuclear cells; Het = heterosexual; MSM = man having sex with men; HBV = hepatits B virus; HBsAg = HBV surface antigen; HBsAb = HBV surface antibodies; HBcAb = HBV core antibodies; HCV = hepatitis C virus; n.d. = not done; und = undetectable.